Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Most Biosimilars Would Need Clinical Trials, ASCO Tells House Panel

Jun 09 2008

• By Cathy Dombrowski

Related Content

Biogeneric Exclusivity Debate: At Least 14 Years Or “Hard And Fast” Combo?

Jun 09 2008

Biogenerics Bill From Reps. Eshoo And Barton “Expects” Limits On Substitution

Feb 25 2008

Biogenerics In Holding Pattern As Legislation And Election Campaigns Simmer

Feb 18 2008

Biogenerics Bill From Pallone/Deal Is A Mere 98 Questions Away From Consensus

Apr 21 2008

Amgen’s European EPO Sales Unaffected By Biosimilars, Company Says

Oct 29 2007

Biosimilar “Interchangeability” Standard Is Double-Edged Sword For Generics

Jul 02 2007

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window